InsidersTradesSigma
Follow the Mycotopia Therapies, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 17 December 2024 (Attribution). Among the most active insiders: Croskery Mark. Every trade is openly available.
Analysts rate Mycotopia Therapies, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Mycotopia Therapies, Inc. is a company focused on developing mushroom-based therapies. It is listed on NASDAQ under the ticker XNAS.